Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes

NCT05653518 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DEVICE: Tandem t:slim X2 with Control-IQ Technology
DEVICE: Sensor augmented pump (SAP) therapy

Sponsor

University of Virginia